Investigating the links between protein buildup and brain barrier issues in Alzheimer's disease.
Preclinical investigation of common mechanistic links between aberrant protein aggregation and blood-brain barrier dysfunction in Alzheimer's disease and Alzheimer's related dementias (AD/ADRD)
This study is looking at how the blood-brain barrier works and its connection to Alzheimer's and similar conditions, to see if problems with this barrier might cause or result from these diseases, which could help find new ways to keep our brains healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10609964 on NIH RePORTER |
What this research studies
This research explores how the blood-brain barrier (BBB) functions and its role in Alzheimer's disease and related dementias. It examines the relationship between protein aggregation, such as amyloid-β and tau, and the breakdown of the BBB, which is crucial for maintaining brain health. By studying these mechanisms, the research aims to understand whether BBB dysfunction is a precursor to neurological disorders or a result of them. The findings could lead to new therapeutic strategies to protect brain function.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related dementias, particularly those experiencing cognitive decline.
Not a fit: Patients with other forms of dementia not related to Alzheimer's or those without cognitive impairment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent or slow the progression of Alzheimer's disease and related dementias.
How similar studies have performed: Previous research has shown promising results in understanding the relationship between BBB dysfunction and neurodegenerative diseases, indicating that this approach has potential for significant breakthroughs.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Silva, Afonso C — University of Pittsburgh at Pittsburgh
- Study coordinator: Silva, Afonso C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.